IFNG and tuberculosis: Clinical trial data also suggested that ID93/GLA-SE enhanced IFN-γ/TNF-α-producing CD4+ T cells in non-exposed TB persons, however only minimal Rv1813 (dormancy-associated antigen)-specific CD4+ T cells were detected9.